Xenon Pharmaceuticals Inc.: Form 8-K, filed Aug 9, 2023
Filed with the SEC on Aug 9, 2023 and accepted by EDGAR at Aug 9, 2023, 20:16 ET.
Items reported
- Item 2.01 Completion of an acquisition or disposition
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-23-040608. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.